9 completed. 9 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
| Phase 2 | 1 | Completed 1 |
Follow Morphological and Microscopic Findings: new trials by email Literature Review of Morphological and Microscopic Findings trials Research Report on Morphological and Microscopic Findings
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy NeuroSAFE procedure, LaserSAFE procedure - Prostate Cancer | Phase 1 / Phase 2 | Completed | University College, London | 21 | 2024-05-15 | 2025-01-10 |
| NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL NWRD08 administered by electroporation - High-grade Squamous Intraepithelial Lesion (HSIL) | Phase 1 | Completed | Newish Technology (Beijing) Co., Ltd. | 9 | 2024-05-07 | 2026-06-25 |
| Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy AIV001 - Keloid, Scar | Phase 1 | Completed | AiViva BioPharma, Inc. | 25 | 2021-06-23 | 2024-12-27 |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. Topical ABI-1968 - HSIL of Cervix, HSIL, High Grade Squamous Intraepithelial Lesions | Phase 1 | Completed | Antiva Biosciences | 8 | 2018-12-21 | 2021-01-13 |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection ABI-1968 - HSIL, HSIL of Cervix | Phase 1 | Completed | Antiva Biosciences | 16 | 2018-01-01 | 2019-07-10 |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection ABI-1968 - HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection | Phase 1 | Completed | Antiva Biosciences | 57 | 2017-08-11 | 2019-02-07 |
| A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers CDX-1127 - CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Completed | Celldex Therapeutics | 90 | 2011-10-01 | 2018-01-31 |
| Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer Immunotherapeutic GSK2302025A, different formulations - Melanoma | Phase 1 | Completed | GlaxoSmithKline | 107 | 2010-07-02 | 2020-11-20 |
| Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia infrared photocoagulation therapy, Infrared Coagulator - Anal Cancer, Precancerous Condition | Phase 1 | Completed | AIDS Malignancy Consortium | 18 | 2003-09-01 | 2014-09-17 |
Squamous Intraepithelial Lesions (5) · Margins of Excision (3) · Anus Neoplasms (2) · Melanoma (2) · Uterine Cervical Dysplasia (2) · Uterine Cervical Neoplasms (2) · Atypical Squamous Cells of the Cervix (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Cicatrix (1) · HIV Infections (1) · Keloid (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Mantle-Cell (1)
Pathological Conditions, Signs and Symptoms (9) · Neoplasms (7) · Neoplasms by Site (7) · Genital Diseases (6) · Urogenital Diseases (6) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases, Female (4) · Urogenital Neoplasms (4) · Genital Neoplasms, Female (3) · Pathologic Processes (3) · Precancerous Conditions (3) · Skin and Connective Tissue Diseases (3) · Uterine Cervical Diseases (3)
Light Coagulation (1) · varlilumab (1)
Antiva Biosciences (3) · AIDS Malignancy Consortium (1) · AiViva BioPharma, Inc. (1) · Celldex Therapeutics (1) · GlaxoSmithKline (1) · Newish Technology (Beijing) Co., Ltd. (1) · University College, London (1)
United States (5) · Australia (2) · China (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Russia (1) · South Africa (1) · United Kingdom (1)
Elizabeth Stier, MD (1) · Greg Shaw (1) · Yang Xiang, M.D. (1)
PMID 27843625, PMID 32380537, PMID 41309506
2009 (1)